What medications should be initiated for a patient with exertional angina and a normal electrocardiogram?

Initial Pharmacotherapy for Exertional Angina with Normal ECG

Start aspirin 75-150 mg daily and a beta-blocker immediately, followed by sublingual nitroglycerin for acute symptom relief. 1

Immediate First-Line Therapy

Antiplatelet Therapy

• Aspirin 75-325 mg daily should be initiated promptly and continued indefinitely unless contraindications exist (hypersensitivity, active bleeding, hemophilia, severe untreated hypertension, or active peptic ulcer). 1
• Clopidogrel should replace aspirin only if the patient has documented aspirin hypersensitivity or major gastrointestinal intolerance. 1

Beta-Blocker Therapy

• Beta-blockers are the recommended initial anti-anginal medication for most patients with exertional angina. 1
• Target doses include: bisoprolol 10 mg once daily, metoprolol CR 200 mg once daily, or atenolol 100 mg daily. 1
• Beta-blockers reduce myocardial oxygen demand by decreasing heart rate, contractility, and blood pressure, while prolonging diastolic perfusion time. 1, 2
• They are particularly indicated if the patient has prior myocardial infarction, hypertension, or high resting heart rate. 1, 2

Sublingual Nitroglycerin

• All patients should receive sublingual nitroglycerin (0.4 mg tablet or spray) for immediate relief of anginal episodes and prophylaxis before activities that trigger symptoms. 1

Secondary Medications to Add

Statin Therapy

• Initiate lipid-lowering therapy with a statin regardless of baseline cholesterol levels. 1
• Statins reduce mortality and adverse ischemic events in patients with coronary artery disease. 1

ACE Inhibitor

• An ACE inhibitor should be started in all patients with chronic coronary syndrome. 1
• This is particularly important if the patient has hypertension, diabetes, left ventricular dysfunction, or heart failure. 1

If Beta-Blockers Are Contraindicated or Not Tolerated

Calcium Channel Blockers

• Use a long-acting calcium channel blocker (CCB) if beta-blockers are contraindicated or cause unacceptable side effects. 1
• Non-dihydropyridine CCBs (verapamil 240-480 mg/day or diltiazem 120-360 mg/day) are preferred as monotherapy alternatives. 1
• Long-acting dihydropyridine CCBs (e.g., amlodipine) can be used but should be combined with a beta-blocker when possible. 1
• Never use immediate-release short-acting dihydropyridines (like nifedipine) without concurrent beta-blockade, as they increase adverse outcomes. 1

Combination Therapy for Inadequate Symptom Control

If symptoms persist on beta-blocker monotherapy:

• Add a long-acting dihydropyridine CCB to the beta-blocker regimen. 1
• Alternatively, add long-acting nitrates (with a nitrate-free interval to prevent tolerance) or ranolazine. 1
• Long-acting nitrates require 10-14 hour nitrate-free intervals daily to maintain efficacy. 1

Critical Contraindications and Pitfalls

• Avoid nitrates within 24 hours of sildenafil use. 1
• Beta-blockers should be used cautiously in patients with severe bradycardia (<50 bpm), greater than first-degree AV block, or severe asthma/COPD. 1, 2
• Non-dihydropyridine CCBs and beta-blockers together may cause excessive bradycardia or heart block in predisposed patients. 1
• If beta-blockers must be discontinued, taper over four weeks to avoid rebound ischemia. 1

Additional Considerations

Risk Factor Modification

• Smoking cessation is mandatory. 1
• Blood pressure control to guideline targets. 1
• Weight reduction if body mass index is elevated. 1

Further Evaluation Needed

Since the ECG is normal but the patient has exertional angina, stress testing or coronary imaging should be arranged to confirm the diagnosis and assess for obstructive coronary disease, microvascular dysfunction, or vasospastic angina. 1 The normal resting ECG does not exclude significant coronary pathology, and troponin levels should be checked if there is any concern for acute coronary syndrome. 1